 22 PM / Updated 12 minutes ago BRIEF-Cerus - Chronic Anemia Phase 3 Study Met Primary Efficacy And Safety Endpoints Reuters Staff 1 Min Read 
Jan 23 (Reuters) - Cerus Corp: 
* CERUS REPORTS POSITIVE TOP-LINE RESULTS FROM CHRONIC ANEMIA PHASE 3 STUDY EVALUATING INTERCEPT RED BLOOD CELLS IN THALASSEMIA PATIENTS 
* CERUS CORP - STUDY SUCCESSFULLY MET PRIMARY EFFICACY AND SAFETY ENDPOINTS 
* CERUS CORP - FULL RESULTS OF STUDY ARE PLANNED FOR SUBMISSION AND PRESENTATION AT UPCOMING SCIENTIFIC CONFERENCES AND FOR PUBLICATION Source text for Eikon: Further company coverage: